EMERGENCY:Severe headache or seizure in a pregnant or postpartum woman? This may be CVST —call040-46324365immediately — 24 hours, 7 days— 24/7
Cerebral Venous Sinus Thrombosis: The Stroke in Young Women That Is Regularly Missed — and Highly Treatable When Found
CVST is a stroke caused not by a blocked artery but by a blood clot in the brain's venous drainage system. It accounts for 10–20% of stroke in young adults in India, strikes disproportionately during pregnancy and the puerperium, and is highly treatable — with up to 80–85% of patients making a full recovery when diagnosed and anticoagulated early.
Blood clots forming in the brain's venous drainage system blocking outflow rather than inflow
Young women especially during pregnancy and the 4 to 6 weeks after delivery puerperium
Pregnancy related CVST rate in India: 450 per 100,000 deliveries far higher than developed countries
Severe progressive headache often the worst headache the patient has ever had
CVST is NOT caused by blocked arteries it is caused by blocked brain veins
Up to 80 to 85 percent make a full recovery one of the best outcomes in stroke medicine
Anticoagulation heparin then warfarin or DOAC started immediately
040 46324365 24 hours
About This Condition
What Is Cerebral Venous Sinus Thrombosis?
Every medical student learns about strokes from blocked arteries. An ischemic stroke: a clot in the middle cerebral artery. A haemorrhagic stroke: a hypertensive small vessel ruptures. These are the arterial strokes — the ones most doctors think of first.
Cerebral venous sinus thrombosis — CVST — is different. It is a stroke caused not by a blocked artery but by a blood clot in the brain's venous drainage system. The cerebral venous sinuses are large channels that drain blood out of the brain and back to the heart. When one of these drains clots off, blood cannot leave the brain normally. Pressure builds. The brain swells. Blood — unable to drain — leaks out into the surrounding tissue, causing haemorrhagic venous infarction. The result is stroke — but of a completely different mechanism and with completely different treatment to arterial stroke.
CVST accounts for 10–20% of stroke in young adults in India — which itself accounts for nearly 30% of all strokes. It is not rare. But it is regularly missed — because its symptoms are non-specific, because it strikes a population (young women) in whom strokes are not expected, and because the critical clinical setting — the weeks after childbirth — is one where symptoms are frequently attributed to the normal difficulties of recovery from delivery.
South Asia, including India, contributed to 40% of strokes in women globally, with young age, female gender in pregnancy and the puerperal period, and dehydration as the critical regional risk factors. India has a specific and serious CVST problem — rooted in the physiology of pregnancy, in traditional postpartum practices, in the prevalence of inherited clotting disorders, and in tropical infections that are uncommon elsewhere.
The good news is compelling: with timely diagnosis and treatment, up to 80–85% of CVST patients make a full recovery. CVST has one of the best prognoses of any stroke type — if it is recognised and treated early. The anticoagulant medication that treats CVST is safe, effective, and available. What is not available in many settings is the awareness to think of CVST in the first place.
At KIMS Neuroscience, Secunderabad, Hyderabad, CVST is on the differential diagnosis for every young adult — and particularly every young woman in the perinatal period — presenting with severe headache, seizure, altered consciousness, or focal neurological symptoms. We investigate urgently and treat immediately.
Book a CVST Consultation
Our cerebrovascular team is available for urgent, emergency CVST assessment — 24 hours, 7 days. Same-day MRI/MRV available.
040-46324365International enquiries: neuroscience@kimshospitals.comWhy Is CVST So Common in India? Understanding the Risk Factors
CVST occurs when the blood becomes too thick or too prone to clotting — in combination with conditions that slow venous flow or damage the venous wall.
Pregnancy and the puerperium — the dominant Indian risk factor
Pregnancy naturally increases the blood's tendency to clot — a protective adaptation to prevent haemorrhage at delivery. After delivery, this hypercoagulable state persists for 4–6 weeks. During this window, the risk of CVST is highest. The rate of pregnancy-related CVST in India is 450 per 100,000 deliveries — far higher than in developed countries, accounting for 9–15% of maternal mortality and morbidity during pregnancy.
A specific and critically important Indian factor: the traditional practice of fluid restriction in postpartum women. In many parts of India and Telangana, cultural practices restrict water intake in the first days or weeks after delivery. Dehydration increases blood viscosity and dramatically increases the risk of venous thrombosis. This practice — combined with the natural hypercoagulability of the puerperium — creates the conditions for CVST.
The message is direct: any woman who develops a severe headache, seizure, altered consciousness, weakness, or speech difficulty in the weeks following delivery must be assessed for CVST as an emergency. This is not a headache to dismiss as postnatal fatigue. It may be a stroke.
Oral contraceptive pills
Oestrogen-containing oral contraceptive pills increase clotting tendency — particularly combined oral contraceptive pills. In combination with an underlying thrombophilia (an inherited clotting disorder), the risk is substantially amplified. Any young woman on oral contraceptives presenting with unexplained headache, seizure, or focal neurological symptoms must have CVST excluded urgently.
Inherited thrombophilia
There is a higher prevalence of inherited thrombophilia in Asian cohorts, contributing significantly to prothrombotic states predisposing to CVST. The most important inherited thrombophilias are: Factor V Leiden mutation, prothrombin gene mutation (G20210A), protein C deficiency, protein S deficiency, antithrombin III deficiency, and elevated Factor VIII. Hyperhomocysteinaemia — elevated blood homocysteine levels, related to folate and B12 deficiency — is particularly prevalent in India and is a significant CVST risk factor. Every young CVST patient at KIMS receives a full thrombophilia screen.
Tropical infections
India's tropical disease profile creates specific CVST risks that differ entirely from Western populations. Tropical infections including malaria, scrub typhus, dengue, and flaviviral encephalitis predispose to CVST through hypercoagulable inflammatory states. Meningitis and mastoiditis — infections of the membranes around the brain and the air cells behind the ear — can spread directly to the adjacent venous sinuses, causing septic CVST.
Head and neck conditions
Sinusitis (inflammation of the paranasal sinuses), otitis media (middle ear infection), and mastoiditis can all propagate septic thrombosis into the adjacent cavernous sinus or transverse sinus. Septic cavernous sinus thrombosis — from spread of facial or dental infection — presents with painful, red, proptotic (bulging) eye and is a neurosurgical and ophthalmological emergency.
Other causes
Autoimmune conditions including antiphospholipid syndrome and lupus. Malignancy. Haematological conditions including polycythaemia vera, thrombocythaemia, and paroxysmal nocturnal haemoglobinuria. Severe dehydration. Head trauma. Lumbar puncture-related changes in CSF pressure.
Dehydration — underappreciated and preventable
In the hot climate of Hyderabad and Telangana, severe dehydration — from gastroenteritis, excessive heat exposure, or restricted fluid intake — is an independent CVST risk factor. When dehydration combines with another trigger (infection, postpartum state, underlying thrombophilia), CVST risk rises sharply.
How Does CVST Present? The Symptoms That Should Raise Suspicion
CVST's clinical presentation is one of the most variable in neurology. It can develop over hours, days, or even weeks. Its symptoms can mimic migraine, meningitis, encephalitis, or raised intracranial pressure from a tumour. This variability is precisely why it is missed.
The headache — present in 70–90% of cases
Headache is the most common presenting symptom in 70–90% of CVST cases. The headache of CVST is typically:
• Severe — often the worst headache the patient has experienced
• Progressive — worsening over hours to days rather than resolving
• Diffuse — not clearly localised to one side
• Sometimes thunderclap in onset — resembling SAH
The headache alone, without any other neurological symptoms, can be the only presentation of CVST — particularly when the thrombosis is confined to one sinus without significant venous infarction. This isolated intracranial hypertension presentation can masquerade as idiopathic intracranial hypertension (pseudotumour cerebri) — and CVST must be excluded in all such patients with MR venography.
Clinical scenarios that should trigger urgent CVST investigation
In a postpartum woman: Any severe headache, new seizure, limb weakness, speech difficulty, altered consciousness, or visual disturbance in the 4–6 weeks after delivery. This is CVST until proven otherwise.
In a young woman on oral contraceptive pills: Progressive or severe headache, seizure, focal neurological symptoms. CVST must be excluded before the headache is attributed to migraine.
In a young adult after a tropical illness: Persistent headache, progressive focal weakness, or seizure following dengue, malaria, or scrub typhus. Tropical infection-associated CVST is under-recognised in India.
Painful, red, bulging eye after facial infection or dental procedure: This is cavernous sinus thrombosis — a septic CVST emergency. Immediate hospitalisation and high-dose antibiotic therapy are required alongside anticoagulation.
In any young adult with stroke-like symptoms and no conventional risk factors: A young person with hemiparesis, aphasia, or seizure without hypertension, diabetes, or atrial fibrillation. CVST — along with AVM, Moyamoya, and thrombophilia — belongs in the differential from the outset.
Additional symptoms of CVST
• Seizures — focal or generalised, occurring in approximately 40% of CVST patients
• Focal weakness (hemiparesis) — present in about 22% of Indian cases
• Speech difficulty (aphasia)
• Visual disturbance — blurred vision from raised intracranial pressure, or visual field loss from occipital involvement
• Diplopia — from sixth nerve palsy caused by raised intracranial pressure
• Papilloedema — disc swelling visible on fundoscopy, indicating raised intracranial pressure
• Altered consciousness — from extensive thrombosis or deep venous system involvement
• Psychiatric symptoms — agitation, confusion
Diagnosis at KIMS
How Is CVST Diagnosed at KIMS?
CVST is a diagnosis that requires specific imaging — it will not be found on a standard CT scan done for headache without dedicated venous sequences. The key investigative steps at KIMS are:
CT brain — the first test
A non-contrast CT brain is performed as the initial emergency scan. In approximately 30% of CVST cases, CT shows a positive finding: the “dense triangle sign” (hyperdense blood in the superior sagittal sinus), the “cord sign” (hyperdense thrombosed cortical vein), or venous haemorrhagic infarcts in atypical locations (near the superior sagittal sinus, bilateral parasagittal infarcts). However, CT is normal in the majority of CVST cases — a normal CT does not exclude CVST.
CT venography
CT venography — performed with intravenous contrast immediately after the non-contrast CT — directly images the cerebral venous sinuses and identifies filling defects (the “empty delta sign”) caused by thrombosis. CT venography is a rapid and reliable test when MRI is not immediately available.
MRI brain with MR Venography (MRV) — the gold standard
MRI brain with DWI identifies venous infarcts and distinguishes them from arterial infarcts by their distribution (crossing arterial territories, bilateral parasagittal, deep bilateral). MR Venography (MRV) directly images the venous sinuses and is the most sensitive and specific non-invasive test for CVST. The combination of MRI and MRV is the investigation of choice at KIMS for all suspected CVST cases that are not acute emergencies requiring immediate CT.
D-dimer blood test
A raised D-dimer (a marker of clot formation and breakdown) supports the diagnosis of CVST. A normal D-dimer in a low-suspicion case can help exclude CVST. However, D-dimer can be normal in isolated cortical vein thrombosis — it should not be relied upon to exclude CVST in high-suspicion cases.
Thrombophilia screen
Blood tests for inherited and acquired thrombophilia — protein C, protein S, antithrombin III, Factor V Leiden, prothrombin mutation, antiphospholipid antibodies, ADAMTS13, homocysteine, Factor VIII — are performed on every CVST patient at KIMS. These results guide the duration of anticoagulation after the acute event.
Infection screen
Full blood count, inflammatory markers, blood cultures, and specific tests for tropical infections where clinically indicated.
Treatment
Treatment of CVST at KIMS
The treatment of CVST is fundamentally different from arterial stroke — and must not be confused with it.
Anticoagulation — the cornerstone of treatment
The mainstay of CVST treatment is anticoagulation — blood-thinning medication that prevents the clot from extending and allows the body's own fibrinolytic system to gradually dissolve the existing thrombus.
The critical point: anticoagulation is used even when there is haemorrhagic venous infarction visible on imaging — the opposite of arterial haemorrhagic stroke, where anticoagulation is contraindicated. In CVST, the haemorrhage is a consequence of venous hypertension from the clot. Treating the clot with anticoagulation reduces the venous pressure and allows the haemorrhage to stabilise and resolve. The risk of not anticoagulating — clot propagation and further haemorrhage — is greater than the risk of anticoagulating a CVST-related haemorrhage.
Acute phase: Low molecular weight heparin (LMWH) given by injection — commenced immediately upon diagnosis confirmation at KIMS.
Transition to oral anticoagulation: After the acute phase, patients transition to oral anticoagulation. Traditionally warfarin was used; current evidence supports direct oral anticoagulants (DOACs — dabigatran, rivaroxaban, apixaban) as safe and effective alternatives with more predictable dosing. At KIMS, anticoagulation choice is individualised based on the patient's thrombophilia results, plans for future pregnancy, and the underlying cause.
Duration of anticoagulation: A minimum of 3–6 months. For patients with inherited thrombophilia, antiphospholipid syndrome, or recurrent CVST — long-term or indefinite anticoagulation is considered.
Managing raised intracranial pressure
In CVST, raised intracranial pressure results from impaired venous outflow causing progressive cerebral oedema and, when haemorrhagic venous infarction is present, a combination of cytotoxic and vasogenic oedema. Acute ICP management at KIMS focuses on four measures:
• Head-of-bed elevation to 30–45 degrees: The simplest and most immediate intervention. Elevation of the head and upper torso reduces cerebral venous engorgement, lowers ICP, and improves venous outflow without compromising cerebral perfusion pressure. Applied in all CVST patients with elevated ICP from the time of admission.
• Mannitol: 20% mannitol (0.25–1 g/kg IV) is an osmotic agent that draws water from oedematous brain tissue into the intravascular compartment, rapidly reducing cerebral oedema and lowering ICP. Used for acute, severe ICP elevation, particularly when signs of cerebral herniation — pupillary asymmetry, posturing, declining consciousness — are present or impending. Repeated doses are given with monitoring of serum osmolality and electrolytes.
• Hypertonic saline: 3% or 7.5% sodium chloride solution used as an osmotic agent alongside or as an alternative to mannitol. Hypertonic saline has the additional advantage of avoiding the hypotension that can accompany mannitol administration, making it the preferred agent when blood pressure is marginal. Both mannitol and hypertonic saline are used at KIMS in CVST with malignant cerebral oedema, often in combination or as sequential agents.
• Decompressive craniectomy: When ICP elevation is severe and unresponsive to medical management — particularly in the setting of large haemorrhagic venous infarction with imminent herniation — decompressive craniectomy is the definitive intervention. Surgical removal of part of the skull allows the swollen brain to expand without compressing the brainstem. This is covered in detail in the surgical section below.
Managing seizures
Anti-epileptic medication is started for patients who present with seizures. At KIMS, levetiracetam is typically the first choice. Duration of anticonvulsant treatment is guided by the clinical course and EEG findings.
Endovascular thrombectomy — for refractory cases
For patients with severe CVST who do not respond to systemic anticoagulation — particularly those with rapidly worsening consciousness or massive clot burden — endovascular mechanical thrombectomy can extract the clot from the venous sinus directly. This is available at KIMS. Endovascular thrombectomy adds mortality benefit in those patients who are refractory to medical management.
Decompressive hemicraniectomy — the life-saving surgical option
When a large haemorrhagic venous infarction causes uncontrollable brain swelling with herniation — compression of the brainstem — decompressive hemicraniectomy is life-saving. Part of the skull is removed to allow the swollen brain to expand without compressing the brainstem. Decompressive hemicraniectomy, when done early, offers mortality benefits in patients with large haemorrhagic venous infarctions. At KIMS, Dr. Panigrahi and the neurosurgical team perform decompressive craniectomy as an emergency procedure for CVST patients with malignant brain swelling.
Treating the underlying cause
For septic CVST (from sinusitis, mastoiditis, dental infection): high-dose intravenous antibiotics — often for weeks — alongside anticoagulation. Surgical drainage of the infected source (mastoidectomy, sinus drainage) may be required. For antiphospholipid syndrome: anticoagulation as above, with rheumatology co-management. For oral contraceptive-related CVST: the OCP is permanently discontinued. Future contraception is planned with non-oestrogen-containing methods.
CVST in Pregnancy and the Postpartum Period — Special Considerations
Given the high burden of pregnancy-related CVST in Hyderabad and Telangana, this section deserves specific emphasis.
During pregnancy
LMWH is safe in pregnancy — it does not cross the placenta. Warfarin crosses the placenta and is teratogenic. DOACs are not recommended in pregnancy. When CVST occurs during pregnancy at KIMS, LMWH is the anticoagulant of choice and is continued throughout the remainder of the pregnancy and postpartum period.
After delivery (puerperium)
The 4–6 weeks after delivery are the highest-risk period. Any severe headache, seizure, or neurological symptom during this period must trigger urgent CVST assessment. Traditional fluid restriction practices must be actively discouraged — adequate hydration in the postpartum period is a primary prevention measure.
After a CVST during one pregnancy, the risk of CVST in future pregnancies is elevated. European Stroke Organization guidelines and current evidence support the use of prophylactic LMWH throughout subsequent pregnancies and the postpartum period for CVST survivors. At KIMS, this is standard practice and is discussed at the pre-discharge counselling appointment.
Future use of oral contraceptives
In women who have suffered a previous CVST, oestrogen-containing contraceptives should be avoided. Non-oestrogen alternatives (progesterone-only pill, copper IUD, barrier methods) are safe. This advice is provided to every female CVST patient at KIMS before discharge.
Outcomes and Recovery
For the majority of CVST patients who receive early diagnosis and treatment, the prognosis is excellent — far better than arterial stroke. Up to 80–85% of patients make a full recovery with timely treatment. Residual deficits — cognitive difficulties, epilepsy, or chronic headaches — occur in approximately 10–15% of patients.
The factors that predict poorer outcomes are: deep venous system involvement (straight sinus, thalamic veins), altered consciousness on admission, large haemorrhagic infarction, and delay in diagnosis. All of these underscore the single most important determinant of outcome: how quickly the diagnosis is made.
At KIMS Neuroscience, CVST outcomes are consistently good because the diagnosis is made promptly, anticoagulation is started immediately, and neurosurgical backup — for decompressive craniectomy or endovascular thrombectomy — is available 24 hours a day.
Follow-up at KIMS after CVST includes:
• Repeat MRI/MRV at 3–6 months to confirm sinus recanalisation
• Thrombophilia results review with guidance on anticoagulation duration
• Neuropsychological assessment for cognitive sequelae
• Pregnancy counselling and contraception advice
• EEG monitoring if seizures occurred
Related Conditions
Explore related cerebrovascular conditions commonly associated with stroke, affecting blood supply to the brain:
FAQs
Frequently Asked Questions
EMERGENCY:Severe headache or seizure in a pregnant or postpartum woman — possible CVST emergency —call040-46324365immediately — 24 hours, 7 days— 24/7
CVST is highly treatable when diagnosed early. At KIMS, we think of it first.
KIMS Neuroscience provides complete CVST management — 24-hour emergency assessment, MRI/MRV and CT venography, immediate anticoagulation, endovascular thrombectomy for refractory cases, decompressive craniectomy when needed, and complete thrombophilia investigation and pregnancy counselling. For every young woman in Hyderabad and Telangana with unexplained neurological symptoms — particularly during and after pregnancy — CVST is our first consideration, not our last.
neuroscience@kimshospitals.com